Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for Thromboprophylaxis in JAK2+ MPN (AIRPORT-MPN)
NCT04243122Phase 2Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Feb 2021
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apixaban in venous thromboembolism (VTE), arterial thrombosis, sponsored by Ottawa Hospital Research Institute. Started Feb 2021; status: completed.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)arterial thrombosis
Beyond the preview
Go deeper on NCT04243122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04243122.